A one-year clinical trial using didanosine, stavudine and nevirapine for highly active antiretroviral therapy.
Zhou
Hua-ying
HY
AIDS Research Laboratory, Division of Infectious Diseases, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zheng
Yu-huang
YH
Zhang
Chun-ying
CY
Ding
Pei-pei
PP
Zou
Wen
W
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D000293:Adolescent; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D018791:CD4 Lymphocyte Count; D002648:Child; D016049:Didanosine / Q000008:administration & dosage; D005260:Female; D015497:HIV-1; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000008:administration & dosage; D012367:RNA, Viral / Q000097:blood; D018119:Stavudine / Q000008:administration & dosage; D013601:T-Lymphocytes / Q000276:immunology
D012367:RNA, Viral; D019829:Nevirapine; D018119:Stavudine; D016049:Didanosine